# HTR3D

## Overview
The HTR3D gene encodes the 5-hydroxytryptamine receptor 3D, a subunit of the serotonin type 3 receptor, which is a ligand-gated ion channel. Unlike other serotonin receptors that are G-protein coupled, the 5-HT3 receptor forms an oligomeric complex composed of five subunits, including the 5-HT3D subunit. This subunit is integral to the structural and functional diversity of the receptor system, although it does not form a functional ion channel independently and requires co-expression with the 5-HT3A subunit for proper function (Niesler2007Characterization; Barnes2009The). The 5-HT3D subunit is predominantly expressed in the gastrointestinal tract, particularly in the colon, where it plays a role in modulating gastrointestinal functions such as motility and secretion (Kapeller2010Serotonin). Additionally, genetic variants of HTR3D have been associated with clinical conditions like obsessive-compulsive disorder and chemotherapy-induced nausea, highlighting its potential significance in both psychiatric and neurogastroenterologic disorders (Celli2016The).

## Structure
The HTR3D protein is a subunit of the human 5-HT3 serotonin receptor, characterized by its unique structural features. It is composed of 279 amino acids and lacks a signal peptide and most of the extracellular domain, including the signature Cys-Cys loop (Barnes2009The). The protein contains four transmembrane regions, which are typical of the 5-HT3 receptor subunits, and a large intracellular loop that influences channel function (Niesler2003Cloning). The transmembrane region 2 (TM2) lines the ion pore, crucial for ion channel conductance, but notably lacks a polar residue within the central ring, which is unusual for such structures (Niesler2003Cloning).

The HTR3D subunit does not form a functional ion channel on its own and requires co-expression with the 5-HT3A subunit to facilitate trafficking to the cell surface (Barnes2009The). The C-terminus of the HTR3D protein is predicted to be intracellular (Niesler2003Cloning). The protein sequence analysis predicts several putative phosphorylation sites, including those for PKC, CKII, cAMP, and tyrosine kinase, indicating potential post-translational modifications (Niesler2003Cloning). The gene encoding HTR3D consists of six exons, fewer than other subunits, and exhibits a distinct genomic organization (Niesler2003Cloning).

## Function
HTR3D encodes a subunit of the 5-HT3 receptor, which is a ligand-gated ion channel activated by serotonin. This receptor is unique among serotonin receptors as it is not G-protein coupled but forms an oligomeric complex composed of five subunits. The 5-HT3D subunit, along with others like 5-HT3C and 5-HT3E, can form heteromeric complexes with the 5-HT3A subunit, which is essential for creating functional receptors. These heteromeric complexes exhibit different functional properties compared to homomeric 5-HT3A receptors (Niesler2007Characterization).

The 5-HT3D subunit is predominantly expressed in the gastrointestinal tract, particularly in the colon, where it is found in the myenteric plexus and submucosal plexus. This suggests a role in modulating gastrointestinal functions such as motility, secretion, and sensation (Kapeller2010Serotonin). Although the 5-HT3D subunit lacks a signal leader sequence and a large N-terminal loop, which raises questions about its ability to form a functional ion channel on its own, it contributes to the structural and functional diversity of the 5-HT3 receptor system (Niesler2007Characterization; Niesler2003Cloning).

## Clinical Significance
The HTR3D gene, encoding a subunit of the serotonin type 3 receptor, has been implicated in several clinical conditions due to its genetic variants and expression patterns. Variants in HTR3D, such as rs1000592 (p.His52Arg), have been associated with obsessive-compulsive disorder (OCD), suggesting a potential role in psychiatric conditions (Celli2016The). Additionally, a coding variant, p.Gly36Ala, in HTR3D has shown a nominal association with chemotherapy-induced nausea and vomiting (CINV), indicating that polymorphisms in this gene may predict susceptibility to CINV (Celli2016The).

The expression of HTR3D, initially thought to be predominantly in the gastrointestinal tract, has been detected in various brain regions, suggesting a broader role in both central and peripheral systems. This expression pattern indicates potential involvement in neurogastroenterologic disorders and psychiatric conditions (Celli2016The). The therapeutic targeting of 5-HT3 receptors, including those involving HTR3D, is well-established for conditions like irritable bowel syndrome and chemotherapy-induced nausea, although treatment responses can vary due to genetic polymorphisms affecting drug metabolism (Celli2016The). Understanding the genetic heterogeneity and tissue-specific expression of HTR3D could lead to more selective and effective treatments.


## References


[1. (Kapeller2010Serotonin) Johannes Kapeller, Dorothee Möller, Felix Lasitschka, Frank Autschbach, Ruud Hovius, Gudrun Rappold, Michael Brüss, Michael D. Gershon, and Beate Niesler. Serotonin receptor diversity in the human colon: expression of serotonin type 3 receptor subunits 5‐ht3c, 5‐ht3d, and 5‐ht3e. Journal of Comparative Neurology, 519(3):420–432, December 2010. URL: http://dx.doi.org/10.1002/cne.22525, doi:10.1002/cne.22525. This article has 63 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cne.22525)

[2. (Barnes2009The) Nicholas M. Barnes, Tim G. Hales, Sarah C.R. Lummis, and John A. Peters. The 5-ht3 receptor – the relationship between structure and function. Neuropharmacology, 56(1):273–284, January 2009. URL: http://dx.doi.org/10.1016/j.neuropharm.2008.08.003, doi:10.1016/j.neuropharm.2008.08.003. This article has 307 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuropharm.2008.08.003)

[3. (Celli2016The) Jacopo Celli, Gudrun Rappold, and Beate Niesler. The human serotonin type 3 receptor gene (htr3a-e) allelic variant database: human mutation. Human Mutation, 38(2):137–147, November 2016. URL: http://dx.doi.org/10.1002/humu.23136, doi:10.1002/humu.23136. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23136)

[4. (Niesler2007Characterization) Beate Niesler, Jutta Walstab, Sandra Combrink, Dorothee Möller, Johannes Kapeller, Jens Rietdorf, Heinz Bönisch, Manfred Göthert, Gudrun Rappold, and Michael Brüss. Characterization of the novel human serotonin receptor subunits 5-ht3c,5-ht3d, and 5-ht3e. Molecular Pharmacology, 72(1):8–17, March 2007. URL: http://dx.doi.org/10.1124/mol.106.032144, doi:10.1124/mol.106.032144. This article has 131 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.106.032144)

[5. (Niesler2003Cloning) Beate Niesler, Bernd Frank, Johannes Kapeller, and Gudrun A Rappold. Cloning, physical mapping and expression analysis of the human 5-ht3 serotonin receptor-like genes htr3c, htr3d and htr3e. Gene, 310:101–111, May 2003. URL: http://dx.doi.org/10.1016/s0378-1119(03)00503-1, doi:10.1016/s0378-1119(03)00503-1. This article has 295 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(03)00503-1)